日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-Analysis

钠-葡萄糖协同转运蛋白2抑制剂对糖尿病状态和蛋白尿水平的影响:一项荟萃分析

Staplin, Natalie; Roddick, Alistair J; Neuen, Brendon L; Anker, Stefan D; Bhatt, Deepak L; Butler, Javed; Cherney, David Z; Docherty, Kieran F; Fletcher, Robert A; Inzucchi, Silvio E; Jardine, Meg; Mahaffey, Kenneth W; McGuire, Darren K; McMurray, John J V; Neal, Bruce; Packer, Milton; Patel, Siddharth M; Perkovic, Vlado; Sabatine, Marc S; Solomon, Scott; Vaduganathan, Muthiah; Wanner, Christoph; Wheeler, David C; Zannad, Faiez; Haynes, Richard; Heerspink, Hiddo J L; Herrington, William G

Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial

维利西呱与射血分数降低的心力衰竭患者的死亡率:VICTOR试验

Butler, Javed; Fioretti, Francesco; McMullan, Ciaran J; Anstrom, Kevin J; Barash, Irina; Bonaca, Marc P; Borentain, Maria; Corda, Stefano; Teixeira, Pedro P; Ezekowitz, Justin A; Gates, Davis; Lam, Carolyn S P; Lewis, Eldrin F; Lindenfeld, JoAnn; Mentz, Robert J; O'Connor, Christopher M; Ponikowski, Piotr; Reddy, Yogesh N V; Rosano, Giuseppe M C; Saldarriaga, Clara; Senni, Michele; Udelson, James; Urbinati, Alessia; Vlajnic, Vanja; Voors, Adriaan A; Xing, Aiwen; Patel, Mahesh J; Zannad, Faiez

Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical Trial

心力衰竭患者死亡方式前的生物标志物、功能状态和生活质量轨迹:FINEARTS-HF随机临床试验的事后分析

Lu, Henri; Kosztin, Annamaria; Claggett, Brian L; Foà, Alberto; Pabón, Maria A; Desai, Akshay S; Jhund, Pardeep S; Henderson, Alasdair D; Merkely, Bela; Lam, Carolyn S P; Senni, Michele; Shah, Sanjiv J; Voors, Adriaan A; Zannad, Faiez; Pitt, Bertram; Amarante, Flaviana; Saarinen, Riitta; De Sanctis, Yoriko; Glasauer, Andrea; McMurray, John J V; Vaduganathan, Muthiah; Solomon, Scott D

Effect of Finerenone on Morbidity and Mortality in CKD

非奈利酮对慢性肾脏病患者发病率和死亡率的影响

Ostrominski, John W; Filippatos, Gerasimos; Claggett, Brian L; Miao, Zi Michael; Desai, Akshay S; Jhund, Pardeep S; Henderson, Alasdair; Rohwedder, Katja; Brinker, Meike D; Scalise, Andrea; Schloemer, Patrick; Lam, Carolyn S P; Senni, Michele; Shah, Sanjiv J; Voors, Adriaan A; Zannad, Faiez; Rossing, Peter; Ruilope, Luis M; Anker, Stefan D; Pitt, Bertram; Agarwal, Rajiv; McMurray, John J V; Solomon, Scott D; Vaduganathan, Muthiah

Albuminuria Is the Key Driver of Kidney Benefit with Aldosterone Receptor Antagonists in Type 2 Diabetes

蛋白尿是醛固酮受体拮抗剂治疗2型糖尿病肾脏获益的关键驱动因素

Ferreira, João Pedro; Mendonça, Luís; Marques, Pedro; Neves, João Sérgio; Zannad, Faiez; Packer, Milton

Finerenone and eGFR Slope across Different Levels of Baseline Albuminuria and eGFR: Insights from FINEARTS-HF

非奈利酮和eGFR斜率在不同基线白蛋白尿和eGFR水平下的变化:来自FINEARTS-HF研究的启示

Mc Causland, Finnian R; Heerspink, Hiddo J L; Vaduganathan, Muthiah; Claggett, Brian L; Desai, Akshay S; Jhund, Pardeep S; McGrath, Martina M; Rohwedder, Katja; Amarante, Flaviana; Brinker, Meike; Schloemer, Patrick; Lam, Carolyn S P; Senni, Michele; Shah, Sanjiv J; Voors, Adriaan A; Zannad, Faiez; Pitt, Bertram; McMurray, John J V; Solomon, Scott D

Hyaluronan and Syndecan-1: Linking Glycocalyx Degradation to Development and Progression of Heart Failure With Preserved Ejection Fraction

透明质酸和 Syndecan-1:将糖萼降解与射血分数保留型心力衰竭的发生和发展联系起来

Rocha-Oliveira, Estela; Lagrange, Jeremy; Jahangiri, Mohammad; Guerci, Philippe; Baudry, Guillaume; Mercier, Nathalie; Monzo, Luca; Leroy, Céline; Lamiral, Zohra; Leite-Moreira, Adelino F; Zannad, Faiez; Ferreira, Joao Pedro; Vasques-Nóvoa, Francisco; Girerd, Nicolas

Effects of SGLT2 inhibitors across the spectrum of albuminuria in cardiovascular-kidney-metabolic conditions: A pooled analysis of randomised trials

SGLT2抑制剂对心血管-肾脏-代谢性疾病中不同程度蛋白尿的影响:随机试验的汇总分析

Ferreira, João Pedro; Marques, Pedro; Anker, Stefan D; Butler, Javed; Filippatos, Gerasimos; Sharma, Abhinav; Vasques-Nóvoa, Francisco; Mendonça, Luís; Neves, João Sérgio; Packer, Milton; Zannad, Faiez

Lifetime benefits of comprehensive medical therapy in heart failure with mildly reduced or preserved ejection fraction

射血分数轻度降低或保留的心力衰竭患者接受综合药物治疗的终身益处

Vaduganathan, Muthiah; Claggett, Brian L; Chatur, Safia; Desai, Akshay S; Jhund, Pardeep S; Vardeny, Orly; Merkely, Bela; Martinez, Felipe; Comin-Colet, Josep; Kerr Saraiva, Jose F; Shah, Sanjiv J; Lam, Carolyn S P; Zannad, Faiez; Docherty, Kieran F; McMurray, John J V; Solomon, Scott D

Interplay Between Heart Failure Events, New-Onset Diabetes, and Finerenone in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

射血分数轻度降低或保留的心力衰竭患者中,心力衰竭事件、新发糖尿病和非奈利酮之间的相互作用

Ostrominski, John W; Lu, Henri; Claggett, Brian L; Desai, Akshay S; Jhund, Pardeep S; Henderson, Alasdair D; Lam, Carolyn S P; Senni, Michele; Shah, Sanjiv J; Voors, Adriaan A; Zannad, Faiez; Pitt, Bertram; Brinker, Meike; Schloemer, Patrick; Rohwedder, Katja; McMurray, John J V; Solomon, Scott D; Vaduganathan, Muthiah